Durable Vision Gains and Greater Fluid Control With Extended Faricimab Dosing vs Aflibercept in Patients With DME

home / rapid-readouts / durable-vision-gains-and-greater-fluid-control-with-extended-faricimab-dosing-vs-aflibercept-in

In this Rapid Readout, Dr Jennifer Lim shares her presentation from the 2023 ARVO annual meeting, highlighting the visual and anatomic outcomes observed in clinical trials of faricimab when administered according to a personalized treatment algorithm for patients with diabetic macular edema (DME).

© 2024 MJH Life Sciences

All rights reserved.